HOYA CORPORATION

What HOYA CORPORATION does

HOYA Corporation is a Tokyo-headquartered, publicly listed Japanese technology company (TYO: 7741) founded in 1941 as an optical glass manufacturer and now operating through two segments: Life Care (eyeglass lenses, contact lenses, intraocular lenses, medical endoscopes) and Information Technology (EUV lithography photomasks, HDD glass substrates, and emerging AR/VR optical components). The Life Care segment represents approximately 65% of consolidated revenue and serves optometry practices, ophthalmologists, hospitals, and consumers through optical retail networks and medical device distributors in over 100 countries. The Information Technology segment supplies over 50% of the global EUV lithography mask blanks consumed in sub-7nm chip production, serving major foundries including TSMC and Samsung.

HOYA's product portfolio is built on deep optical materials science, with proprietary technologies including D.I.M.S. (Defocus Incorporated Multiple Segments) for pediatric myopia management, anti-blue-light lens coatings, progressive multifocal lens designs pioneered in 1967, and photomask blanks engineered to the tolerances required for 2nm-3nm semiconductor nodes. The 2025 divestiture of its voice synthetic software business signals a deliberate refocus on core medical, vision care, and semiconductor optics, while bolt-on M&A in endoscopic ultrasound and a long-term Hitachi diagnostics and imaging partnership underscore continued medical device expansion.

The company monetizes almost exclusively via hardware sales (B2B for photomasks and medical devices, B2B2C for lenses through retail networks) with multi-year enterprise contracts for semiconductor and medical customers. FY2025 full-year revenue guidance stands at 940 billion yen (Q3 FY2025 actuals: 244.7 billion yen, +11% YoY; pretax profit +70%). HOYA maintains a fortress balance sheet with net cash exceeding 200 billion yen, market capitalization above 6.8 trillion yen, R&D spend of 4-5% of revenue, and a workforce of 37,000+ across approximately 40 countries.

Name

HOYA CORPORATION

Legal name

HOYA株式会社 (HOYA Corporation)

Website

http://www.hoya.co.jp

Company type

Public

Founded year

1941

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

HOYA Corporation is a Japanese diversified optics manufacturer operating two segments: Life Care (eyeglass lenses, intraocular lenses, medical endoscopes) and Information Technology (EUV lithography photomasks, HDD glass substrates), serving foundries like TSMC and Samsung plus global optical retail and medical device channels across 100+ countries.

Ownership category

akta.pro rank

Product category

Precision Optics & Photonics Manufacturing

NAICS

Ophthalmic Goods Manufacturing (339115)

SIC

Ophthalmic Goods (3851), Surgical & Medical Instruments & Apparatus (3841), Optical Instruments & Lenses (3827)

akta.pro primary industry

Optical Dispensing & Eyewear Devices (Frames, Lenses, Lens Edging/Finishing Equipment) (HLAHAJAD)

akta.pro secondary industries

Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics) (HLAHAJAH), Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions) (HLAHAJAE)

Keywords

• Optical lens manufacturing
• Semiconductor photomasks
• Medical endoscopy devices
• Intraocular lens implants
• Precision optics components

Headquarters

HQ city

Shinjuku

HQ country

Japan

HQ region

Asia

Offices5 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Life Care Segment - Eyeglass Lenses: The Life Care segment (eyeglass lenses, contact lenses, intraocular lenses) represents approximately 65% of HOYA's total revenue as of FY ending March 2025. Eyeglass lens sales grew 11% year-over-year in Q3 FY2025, driven by double-digit growth in Europe and MiYOSMART myopia management lenses. Contact lens sales grew 4%, while intraocular lens production capacity is planned to increase by 15% by fiscal 2025.
2. Life Care Segment - Medical Devices: Medical products including intraocular lenses and medical endoscopes. The segment covers eyeglass lenses, contact lenses, and intraocular lenses, generating 151.5 billion yen in Q3 FY2025 revenue. HOYA is pursuing bolt-on acquisitions in endoscopic ultrasound and surgical imaging to expand this sub-segment.
3. Information Technology Segment - Semiconductor Photomasks: HOYA maintains over 50% global market share in EUV lithography mask blanks critical for sub-7nm chip manufacturing. The EUV photomask business is tied to semiconductor capital spending cycles and AI-driven demand. The company is expanding EUV mask blank production capacity for advanced nodes (2nm-3nm).
4. Information Technology Segment - HDD Glass Substrates: Hard disk drive (HDD) glass substrates for data storage applications. This business segment shows cyclical patterns tied to data center investment trends. HOYA faces potential headwinds from HDD-to-SSD demand shifts affecting glass substrate sales.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels4 records

Core offering

HOYA Corporation manufactures and sells precision optical products across two segments. The Life Care segment produces eyeglass lenses (including MiYOSMART myopia management and Sensity photochromic lines), contact lenses, intraocular lenses for cataract surgery, and medical endoscopes for minimally invasive procedures. The Information Technology segment supplies extreme ultraviolet (EUV) lithography mask blanks critical for sub-7nm and 2nm-3nm semiconductor manufacturing, HDD glass substrates for data storage, and developing AR/VR optical components. The company serves semiconductor foundries, hospitals, optical retailers, and optometry practices across more than 100 countries.

Product overview

HOYA Corporation operates as a diversified technology company with two main business segments serving distinct high-growth markets. The Life Care segment (approximately 65% of revenue) encompasses eyeglass lenses (including MiYOSMART myopia management lenses with D.I.M.S. technology, Sensity Colours photochromic lenses, and anti-blue-light coatings), contact lenses, intraocular lenses, and medical endoscopes for minimally invasive treatments. The Information Technology segment includes semiconductor photomasks (particularly EUV mask blanks critical for sub-7nm chip manufacturing with over 50% global market share), hard disk drive (HDD) glass substrates, and emerging augmented reality optical components. The company is pursuing expansion through EUV mask capacity increases, 15% intraocular lens production growth, bolt-on acquisitions in endoscopic imaging, and development of AR/VR optical components for technology company partners.

Differentiator

Problem solved

Functional benefit

Brands

• MiYOSMART: Myopia management lenses for children with D.I.M.S. technology
• Sensity
• MiYOSMART
• Sensity Colours

Products and services

• EUV Lithography Mask Blanks (Photomasks) High-precision mask blanks essential for extreme ultraviolet (EUV) lithography in semiconductor manufacturing, supporting sub-7nm chip production at advanced nodes (2nm-3nm). Sold directly to major semiconductor foundries including TSMC and Samsung as a critical enabler of advanced node yields.
• Intraocular Lenses (IOLs) Implantable lenses used in cataract surgery. HOYA is increasing production capacity by 15% by fiscal 2025 in response to aging-population-driven cataract procedure volume growth worldwide.
• Medical Endoscopes Endoscopic imaging devices and systems for minimally invasive medical procedures, supporting diagnostic and therapeutic applications across medical specialties. Distributed through medical device distributors and procurement channels into hospitals and surgical centers worldwide.
• MiYOSMART Myopia Management Lenses (D.I.M.S. Technology) Myopia management spectacle lenses using proprietary Defocus Incorporated Multiple Segments (D.I.M.S.) technology, clinically proven to slow myopia progression in children. Distributed through optometry stores and eye care professionals globally.
• Sensity Colours Photochromic Lenses Fashion tint photochromic lens collection with UV protection, offering adaptive light transmission for comfort and style. Sold through optical retail and optometry networks.
• Sensity Photochromic Lenses Photochromic spectacle lenses with UV protection and adaptive tinting technology, marketed as the Sensity sub-brand for vision correction with light-adaptive comfort.
• HDD Glass Substrates Glass substrates for hard disk drives supporting data center and storage infrastructure in the big data society. Tied to HDD demand cycles and data center investment trends.
• AR/VR Optical Components Camera lenses and optical components developed for augmented reality glasses, supplied through partnerships with multiple technology companies. Emerging product area within the Information Technology segment.

Quantifiable outcome

• EUV lithography photomask market share exceeding 50% globally
• +5 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core and minor.

• HitachicoreStrategic or Co-development Partner · 5 September 2025HOYA entered a long-term technical partnership with Hitachi covering diagnostics and imaging technologies. The partnership aims to leverage synergies between HOYA's optical expertise and Hitachi's diagnostic/imaging capabilities, strengthening competitiveness in medical technology markets. This partnership aligns with HOYA's strategy to focus on core medical technologies and high-growth sectors like ophthalmic devices and endoscopic imaging.
• Hoya Technosurgical Co., Ltd.coreStrategic or Co-development Partner · 5 September 2025HOYA Technosurgical, a subsidiary of HOYA Corporation, specializes in medical endoscopy and surgical imaging. In April 2024, an employee was arrested for making inappropriate payments to doctors, resulting in penalties from the Medical Device Industry Fair Trade Council. HOYA Corporation formulated prevention measures with external experts and its compliance department to ensure compliance with relevant laws and regulations.
• JDI Technology (Japan Display Inc.)minorStrategic or Co-development Partner · 16 May 2025HOYA established a joint venture with JDI Technology in China to manufacture and distribute optical products in the Chinese market, expanding its presence in the Asia-Pacific eyewear market through local production and distribution capabilities.

Scale indicators9 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Bausch + Lomb (Bausch Health): Major global ophthalmic company with directly comparable product portfolio spanning contact lenses (Biotrue, Ultra), intraocular lenses for cataract surgery, and prescription eyeglass lens coatings — head-to-head competitor to HOYA's Life Care segment at Vision Expo events.
• CooperVision: Major contact lens manufacturer (part of CooperCompanies) directly competing with HOYA's contact lens offerings through optometry retail channels, with comparable global distribution and product portfolio breadth across daily, two-week, and specialty lenses.
• Carl Zeiss Meditec: German medical technology division of Zeiss competing with HOYA across ophthalmic surgical devices, intraocular lenses for cataract surgery, and refractive surgery (LASIK) equipment — directly overlapping in ophthalmology clinics globally.
• Nikon (Eyewear): Japanese optical company with premium eyeglass lens business (Nikon Optical) competing with HOYA in the high-end prescription lens segment, leveraging shared Japanese precision optics heritage and global optical retail distribution.
• Johnson & Johnson Vision: Division of J&J competing head-to-head with HOYA in contact lenses (Acuvue brand family) and cataract surgery IOLs (TECNIS), leveraging similar optometry and ophthalmology distribution channels globally.
• EssilorLuxottica: World's largest eyewear and lens company combining frames/lenses manufacturing (Essilor) with retail (Luxottica). Direct competitor to HOYA in eyeglass lenses, particularly premium progressive and myopia management categories, and overlapping presence at Vision Expo.
• Toppan Photomasks: Direct competitor in semiconductor photomasks, including the EUV mask blank market where HOYA holds >50% share. Comparable in serving advanced-node foundries with high-precision lithography components.
• Alcon: Swiss-domiciled pure-play ophthalmology company with leading position in intraocular lenses (AcrySof family), surgical equipment, and contact lens solutions — directly competing with HOYA in cataract surgery products and eye care professional channels.

Broad incumbents

• FUJIFILM Healthcare: Diversified Japanese conglomerate with healthcare division that competes with HOYA Pentax in medical endoscopy and surgical imaging, plus broader medical device portfolio that overlaps with HOYA's medical expansion strategy.
• Olympus (Medical): Global leader in medical endoscopy competing directly with HOYA's Pentax-derived endoscopy franchise, with overlapping hospital customer base in gastroenterology and stronger brand recognition among surgeons globally.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A6 records

Investments9 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HOYA CORPORATION